Results of the treatment with standard-dose chemotherapy
| Study type . | Reference . | No. of patients . | No. operated . | No. chemotherapy-treated . | Type of chemotherapy . | Overall response (complete response), % . | Median survival, mo (range) . |
|---|---|---|---|---|---|---|---|
| Retrospective | 62 | 24 | 12 | 11 | CHOP, BACOP, ProMACE-MOPP | NG (NG) | 10 (0-196) |
| Retrospective | 16 | 31 | 25 | 24 | CHOP, VAMP, PEACE-BOM | 58 (32) | 7.5 (0-83) |
| Retrospective | 61 | 1 | 1 | 1 | Hyper-CVAD | 100 (100) | 34 |
| Retrospective | 31 | 10 | 7 | 10 | CHOP | NG (50) | 5 (1-12) |
| Retrospective | 64 | 54 | 49 | 31 | CHOP, CHOP-like | 32 (32) | 7 (0-140) |
| Prospective | 58 | 23 | 13 | 15 | CHOP | NG (35) | 7 (NG) |
| Prospective | 63 | 10 | 10 | 10 | CHOEP | 60 (30) | 7 (2-16) |
| Study type . | Reference . | No. of patients . | No. operated . | No. chemotherapy-treated . | Type of chemotherapy . | Overall response (complete response), % . | Median survival, mo (range) . |
|---|---|---|---|---|---|---|---|
| Retrospective | 62 | 24 | 12 | 11 | CHOP, BACOP, ProMACE-MOPP | NG (NG) | 10 (0-196) |
| Retrospective | 16 | 31 | 25 | 24 | CHOP, VAMP, PEACE-BOM | 58 (32) | 7.5 (0-83) |
| Retrospective | 61 | 1 | 1 | 1 | Hyper-CVAD | 100 (100) | 34 |
| Retrospective | 31 | 10 | 7 | 10 | CHOP | NG (50) | 5 (1-12) |
| Retrospective | 64 | 54 | 49 | 31 | CHOP, CHOP-like | 32 (32) | 7 (0-140) |
| Prospective | 58 | 23 | 13 | 15 | CHOP | NG (35) | 7 (NG) |
| Prospective | 63 | 10 | 10 | 10 | CHOEP | 60 (30) | 7 (2-16) |
BACOP indicates bleomycin, doxorubicin, cyclophosphamide, vincristine, prednisone; C, complete response; CHOP, cyclophosphamide, doxorubicin, vincristine, prenisone; CHOEP, same drugs as in CHOP plus etoposide; CT, chemotherapy; Hyper-CVAD: cyclophosphamide, vincristine, dexamethasone, methotrexate, cytarabine; NG, not given; O, overall response; PEACE-BOM, prednisolone, etoposide, doxorubicin, cyclophosphamide-bleomycin, vincristine, methotrexate; ProMACE-MOPP, prednisone, doxorubicin, cyclophosphamide, etoposide, mechlorethamine, vincristine, procarbazine; and VAMP, vincristine, doxorubicin, high-dose methotrexate, prednisolone.